TecTraum Inc., dedicated to providing the world’s first point-of-care treatment for concussions, announced the completion of the pro2cool®clinical trial.
There is no doubt that navigating medical device regulations can be daunting. Luckily, Nottingham Spirk has a golden track record, and we are here to help.
Nottingham Spirk's Director of Insights Amanda Beacher was recently quoted by Clinical Trials Arena regarding the FDA's new guidance on patient advisors.
NS client-partner Sterifre Medical announces a milestone development in the fight against COVID-19 and other contagious pathogens in health care settings.
The FDA has designated TecTraum's pro2cool® - dedicated to providing the world’s first point-of-care treatment for concussions - as a Breakthrough Device.
Crain's Cleveland Business first published this article about Northeast Ohio's significant role in getting the Sterifre AURA disinfectant system to market.
Nottingham Spirk and CardioInsight developed EC VUE Sensor Array vest, acquired by medical device company Medtronic earlier this year for over $100 million.
Drawing on our experience with medical systems development, we worked closely with ViewRay to enhance the patient and technician's use experience, from what the patient sees and feels, to the function
